AH股溢价

Search documents
8月7日中远海发AH溢价达132.6%,位居AH股溢价率第11位
Jin Rong Jie· 2025-08-07 08:52
Group 1 - The Shanghai Composite Index rose by 0.16% to close at 3639.67 points, while the Hang Seng Index increased by 0.69% to 25081.63 points [1] - China Merchants Industry Holdings Co., Ltd. (the "Company") has an A/H premium of 132.6%, ranking 11th among A/H shares [1] - The Company is a subsidiary of China Ocean Shipping Group Co., Ltd. and specializes in shipping logistics and financial operations [1] Group 2 - The Company was established in 1997 and is headquartered in Shanghai, listed on both Hong Kong and Shanghai stock exchanges [1] - The Company focuses on container manufacturing, leasing, and shipping leasing, supported by investment management for integrated development [1] - The container manufacturing business has an annual production capacity of over 1.4 million TEUs, ranking second globally, serving major shipping lines and leasing companies [1]
8月6日中船防务AH溢价达87.7%,位居AH股溢价率第38位
Jin Rong Jie· 2025-08-06 08:43
Group 1 - The Shanghai Composite Index rose by 0.45%, closing at 3633.99 points, while the Hang Seng Index increased by 0.03%, closing at 24910.63 points [1] - China Shipbuilding Defense's A-H share premium reached 87.7%, ranking 38th among A-H share premium rates [1] - At the close, China Shipbuilding Defense's A-shares were priced at 30.6 yuan, with a gain of 7.41%, and H-shares were priced at 17.8 HKD, up by 7.75% [1] Group 2 - China Shipbuilding Defense Equipment Co., Ltd. is a major shipbuilding enterprise under China Shipbuilding Group, originally established as Guangzhou Shipyard International Co., Ltd. [1] - The company was listed in Shanghai and Hong Kong in 1993, becoming the first A+H share listed shipbuilding enterprise in China [1] - To promote industry consolidation and enhance competitiveness, China Shipbuilding Defense acquired several companies in 2014 and 2015, integrating quality shipbuilding assets in South China [1] - The company aims to become a leading enterprise in the global marine and heavy equipment market, focusing on technology and service excellence [1]
8月6日康希诺AH溢价达85.6%,位居AH股溢价率第40位
Jin Rong Jie· 2025-08-06 08:43
8月6日,上证指数涨0.45%,收报3633.99点,恒生指数涨0.03%,收报24910.63点。 康希诺AH溢价达85.6%,位居AH股溢价率第40位。当日收盘,康希诺A股报88.48元,涨幅6.13%,H股 报52.05港元,上涨9.21%。 *注:AH股是指同时在A股和港股上市的公司,溢价(A/H)越大,说明H股相比A股越便宜。 本文源自:金融界 作者:行情君 资料显示,康希诺生物股份公司2009年成立于中国,以在世界范围内提供预防和治疗感染类疾病的解决 方案为己任,专注于创新、优质、可及的人用疫苗的研发、生产和商业化,是行业领先的高科技生物制品 企业。康希诺生物的使命始终是"为全球提供创新、优质、可及的疫苗",以达到"创新不止,世界无疫"的 企业愿景。公司已登陆香港联交所主板H股(股票代码6185.HK)和上海证券交易所科创板A股(股票代码 688185),是中国科创板开板以来首支"A+H"疫苗股。 ...
8月6日新天绿能AH溢价达99.57%,位居AH股溢价率第32位
Jin Rong Jie· 2025-08-06 08:43
Core Viewpoint - The article highlights the performance of the Shanghai Composite Index and the Hang Seng Index on August 6, along with the premium of New Tian Green Energy's A-shares over H-shares, indicating a significant investment opportunity in the renewable energy sector [1]. Company Overview - New Tian Green Energy Co., Ltd. was established on February 9, 2010, by Hebei Construction Investment and Construction Investment Water Affairs [1]. - The company is primarily engaged in the development and utilization of renewable and clean energy, with operations in wind power, photovoltaic, and natural gas sectors [1]. - New Tian Green Energy has wind and photovoltaic projects across various regions in China, including Hebei, Shanxi, Xinjiang, Shandong, Yunnan, and Inner Mongolia [1]. Market Performance - On August 6, New Tian Green Energy's A-shares closed at 7.75 yuan, with an increase of 0.65%, while its H-shares closed at 4.24 Hong Kong dollars, up by 0.24% [1]. - The A/H premium for New Tian Green Energy reached 99.57%, ranking it 32nd among AH shares, suggesting that H-shares are relatively cheaper compared to A-shares [1].
8月6日中国通号AH溢价达71.71%,位居AH股溢价率第50位
Jin Rong Jie· 2025-08-06 08:43
Core Viewpoint - The article highlights the performance of the Shanghai Composite Index and the Hang Seng Index on August 6, along with the premium of China Railway Signal & Communication Corporation (China Tonghao) in the A/H share market, indicating its position as a leading provider in the rail transit control system industry [1][2]. Company Overview - China Railway Signal & Communication Corporation, referred to as China Tonghao, is a large central enterprise directly supervised by the State-owned Assets Supervision and Administration Commission (SASAC) [1]. - The company specializes in rail transit control technology and is recognized as a global leader in providing rail transit control systems [1]. - China Tonghao has a complete industrial chain that includes investment and financing, design and research, system integration, equipment manufacturing, engineering services, and operation maintenance [1]. - The company is responsible for the formulation of equipment standards, technical standards, and product standards for rail transit control systems in China [1]. Financial Performance - China Tonghao has achieved an A-grade in operational performance assessments for four consecutive years [1]. - The company successfully listed on the Hong Kong Stock Exchange in 2015 and became the first central enterprise and the first A+H share company to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2019 [1].
8月6日中远海发AH溢价达132.24%,位居AH股溢价率第13位
Jin Rong Jie· 2025-08-06 08:43
8月6日,上证指数涨0.45%,收报3633.99点,恒生指数涨0.03%,收报24910.63点。 中远海发AH溢价达132.24%,位居AH股溢价率第13位。当日收盘,中远海发A股报2.51元,涨幅 0.8%,H股报1.18港元,下跌0.84%。 资料显示,中远海运发展股份有限公司(「公司」)是中国远洋海运集团有限公司(「中远海运集团」)所 属专门从事航运物流产融运营的公司,是中远海运集团旗下核心产业之一。公司成立于1997年,总部设在 上海,是一家在香港、上海两地上市的公司。公司致力于围绕航运物流产业主线,以集装箱制造、集装箱 租赁及航运租赁业务为核心,以投资管理为支撑,实现产融投一体化发展。公司集装箱制造业务从事国际 标准干货箱、冷藏箱及特种箱的研究开发和生产销售,设计年产能超过140万TEU,位居世界第二,客户涵 盖全球知名班轮公司和各大租箱公司。公司深化集装箱租造协同,以科技创新、绿色低碳转型为抓手提 升核心竞争力,打造世界一流物流装备科技企业。 *注:AH股是指同时在A股和港股上市的公司,溢价(A/H)越大,说明H股相比A股越便宜。 本文源自:金融界 作者:行情君 ...
8月6日弘业期货AH溢价达201.29%,位居AH股溢价率第一位
Jin Rong Jie· 2025-08-06 08:43
Group 1 - The Shanghai Composite Index rose by 0.45%, closing at 3633.99 points, while the Hang Seng Index increased by 0.03%, closing at 24910.63 points [1] - Hongye Futures has the highest A/H premium at 201.29%, indicating that its H-shares are relatively cheaper compared to A-shares [1] - As of the close, Hongye Futures' A-shares were priced at 12.28 yuan, down by 0.16%, while its H-shares were priced at 4.45 HKD, up by 2.3% [1] Group 2 - Hongye Futures Co., Ltd. was established in 1995 and is a state-owned enterprise fully owned by Jiangsu Provincial State-owned Assets Supervision and Administration Commission [1] - The company operates in various sectors including commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, and fund sales, with 38 branches in major financial centers across China [1] - Hongye International Financial, a wholly-owned subsidiary, focuses on overseas securities and futures trading, asset management, and investment consulting, covering major global exchanges [1] - Hongye Capital, another wholly-owned risk management subsidiary, specializes in bulk commodity trading and risk management, serving as a market maker for multiple futures products [1] - The company has received several honors, including "National Civilized Unit" and "China's Best Futures Company" [1]
8月5日弘业期货AH溢价达208.79%,位居AH股溢价率第一位
Jin Rong Jie· 2025-08-05 08:53
Group 1 - The Shanghai Composite Index rose by 0.96% to close at 3617.6 points, while the Hang Seng Index increased by 0.68% to 24902.53 points [1] - Hongye Futures has the highest A/H premium at 208.79%, with its A-shares closing at 12.3 yuan, up 1.74%, and H-shares at 4.35 HKD, up 3.33% [1] - Hongye Futures Co., Ltd. was established in 1995 and is a state-owned enterprise fully owned by Jiangsu Provincial State-owned Assets Supervision and Administration Commission [1] Group 2 - The company operates in various sectors including commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, and fund sales [1] - Hongye Futures has established 38 branches in major financial centers and key cities across China, ranking among the top in the country [1] - The company has received multiple honors, including "National Civilized Unit" and "China's Best Futures Company" [1]
8月5日中海油服AH溢价达117.32%,位居AH股溢价率第22位
Jin Rong Jie· 2025-08-05 08:53
Group 1 - The Shanghai Composite Index rose by 0.96% to close at 3617.6 points, while the Hang Seng Index increased by 0.68% to 24902.53 points [1] - China Oilfield Services Limited (COSL) has an AH premium of 117.32%, ranking 22nd among AH shares [1] - COSL's A-shares closed at 13.87 yuan with a gain of 0.22%, and H-shares closed at 6.97 HKD, up by 0.58% [1] Group 2 - COSL is a major integrated oilfield service provider globally, offering services across all stages of offshore oil and gas exploration, development, and production [1] - The company's services are categorized into four main types: geophysical exploration services, drilling services, oilfield technical services, and marine services [1] - COSL was publicly listed on the Hong Kong Stock Exchange on November 20, 2002, and has been trading in the U.S. OTC market since March 26, 2004, and on the Shanghai Stock Exchange since September 28, 2007 [1]
8月5日复旦张江AH溢价达177.33%,位居AH股溢价率第四位
Jin Rong Jie· 2025-08-05 08:53
Group 1 - The Shanghai Composite Index rose by 0.96% to close at 3617.6 points, while the Hang Seng Index increased by 0.68% to 24902.53 points [1] - Fudan Zhangjiang's A/H premium reached 177.33%, ranking fourth among A/H shares [1] - Fudan Zhangjiang's A-shares closed at 10.92 yuan, down 0.27%, and H-shares closed at 4.3 HKD, up 1.65% [1] Group 2 - Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, Shanghai, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1] - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a knowledge-based innovation enterprise [1] - Fudan Zhangjiang has developed competitive advantages in areas such as gene technology drugs, photodynamic technology drugs, nanotechnology drugs, and oral solid dosage technology drugs, with new products expected to be launched in the market [1]